{
  "num_tested_probands": [
    1,
    0
  ],
  "num_positive_het_probands": [
    0,
    0
  ],
  "positive_phenotypes": [
    [
      "Hyperkinetic movement disorder",
      "Neurodevelopmental disorder",
      "Mitochondrial disease",
      "Aminoacyl tRNA synthetase deficiency"
    ],
    [
      "Hyperkinetic movement disorder",
      "Uncontrollable dys-tonic and ballistic movements"
    ]
  ],
  "num_compound_or_double_hets": [
    2,
    0
  ],
  "explanation": {
    "num_tested_probands": [
      "The report states that the patient was referred to the movement disorders outpatient clinic at the age of 30 years, indicating that only one proband was tested.",
      "Not specified in the report"
    ],
    "num_positive_het_probands": [
      "There is no mention of any probands being heterozygous for a pathogenic variant in the report.",
      "Not specified in the report"
    ],
    "positive_phenotypes": [
      "The patient's clinical presentation included hyperkinetic movement disorder, neurodevelopmental disorder, mitochondrial disease, and aminoacyl tRNA synthetase deficiency. These phenotypes are listed as positive phenotypes associated with the patient.",
      "Table S1: Differential diagnosis of mitochondrial disorders as a result of nuclear DNA mutations resulting in similar phenotypes."
    ],
    "num_compound_or_double_hets": [
      "The report states that the patient has compound or double heterozygous mutations in WARS2, indicating 2 individuals reported to have this mutation.",
      "Not specified in the report"
    ]
  }
}